Joshkon, A.; Heim, X.; Dubrou, C.; Bachelier, R.; Traboulsi, W.; Stalin, J.; Fayyad-Kazan, H.; Badran, B.; Foucault-Bertaud, A.; Leroyer, A.S.;
et al. Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis—Contribution of New Antibodies for Therapy. Biomedicines 2020, 8, 633.
https://doi.org/10.3390/biomedicines8120633
AMA Style
Joshkon A, Heim X, Dubrou C, Bachelier R, Traboulsi W, Stalin J, Fayyad-Kazan H, Badran B, Foucault-Bertaud A, Leroyer AS,
et al. Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis—Contribution of New Antibodies for Therapy. Biomedicines. 2020; 8(12):633.
https://doi.org/10.3390/biomedicines8120633
Chicago/Turabian Style
Joshkon, Ahmad, Xavier Heim, Cléa Dubrou, Richard Bachelier, Wael Traboulsi, Jimmy Stalin, Hussein Fayyad-Kazan, Bassam Badran, Alexandrine Foucault-Bertaud, Aurelie S. Leroyer,
and et al. 2020. "Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis—Contribution of New Antibodies for Therapy" Biomedicines 8, no. 12: 633.
https://doi.org/10.3390/biomedicines8120633
APA Style
Joshkon, A., Heim, X., Dubrou, C., Bachelier, R., Traboulsi, W., Stalin, J., Fayyad-Kazan, H., Badran, B., Foucault-Bertaud, A., Leroyer, A. S., Bardin, N., & Blot-Chabaud, M.
(2020). Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis—Contribution of New Antibodies for Therapy. Biomedicines, 8(12), 633.
https://doi.org/10.3390/biomedicines8120633